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ABSTRAK
Sistem imun, proses inflamasi serta hipertensi saling berkaitan. Sistem imun alamiah dan adaptif memicu 
proses inflamasi, mengakibatkan peningkatan tekanan darah yang merangsang kerusakan organ. Sel pada sistem 
imun alamiah memproduksi ROS seperti superoksida dan hidrogen peroksida yang bertujuan membunuh patogen. 
Proses inflamasi jangka-panjang meningkatkan produksi ROS, menyebabkan stress oksidatif, mengakibatkan 
disfungsi endotel. Endotel berfungsi mengatur tonus dan struktur pembuluh darah. Saat inflamasi, bioavaibilitas 
NO menurun, mengganggu fungsi utamanya, sehingga mencegah relaksasi dan vasodilatasi pembuluh darah. 
Sel T efektor dan limfosit regulatori, bagian dari sistem imun adaptif, berperan pada konstriksi pembuluh 
darah pada hipertensi. Sinyal dari sistem saraf pusat dan APC mengaktivasi diferensiasi limfosit T efektor, 
dan mempercepat melalui Th-1 dan fenotip Th-17. Efektor Th-1 dan Th-17 berpartisipasi dalam inflamasi, 
mengakibatkan peningkatan tekanan darah. Salah satu bagian CD4+ adalah regulatory T cells (Tregs) yang 
menekan aktivasi respons imun dengan memproduksi sitokin imunosupresif seperti TGF-β dan IL-10. Transfer 
adoptif dari sel Tregs menurunkan stres oksidatif pada pembuluh darah, disfungsi endotel, infiltrasi dari makrofag 
aorta dan sel T serta kadar sitokin proinflamasi dalam sirkulasi plasma.
Kata kunci: aktifasi sistem imun, proses inflamasi, disfungsi endotel, hipertensi.
ABSTRACT
The immune system, inflammation and hypertension are related to each other. Innate and adaptive immunity 
system triggers an inflammatory process, in which blood pressure may increase, stimulating organ damage. 
Cells in innate immune system produce ROS, such as superoxide and hydrogen peroxide, which aimed at killing 
pathogens. Long-term inflammation process increases ROS production, causing oxidative stress which leads to 
endothelial dysfunction. Endothelial function is to regulate blood vessel tone and structure. When inflammation 
lasts, NO bioavailability decreases, disrupting its main function as vasodilator, so that blood vessels relaxation 
and vasodilatation are absent. Effector T cells and regulatory lymphocytes, part of the adaptive immune system, 
plays role in blood vessels constriction in hypertension. Signals from central nervous system and APC activates 
effector T lymphocyte differentiation and accelerate through Th-1 and Th-17 phenotypes. Th-1 and Th-17 effectors 
participate in inflammation which leads to increased blood pressure. One part of CD4+ is the regulatory T cells 
(Tregs) that suppress immune response activation as they produce immunosuppressive cytokines, such as TGF-β 
and IL-10. Adoptive transfer of Tregs cells can reduce oxidative stress in blood vessels, endothelial dysfunction, 
infiltration of aortic macrophages and T cells as well as proinflammatory cytokine levels in plasma circulation. 
Keywords: immune system activation, inflamation process, endothelial dysfunction, hypertension.
Vol 49 • Number 2 • April 2017                                                               Inflammation, immunity, and hypertension
159
INTRODUCTION
Hypertension is a major risk factor for 
cardiovascular disease events that contribute 
broadly to morbidity and mortality worldwide. 
Hypertension is a complex condition, with 
90% of the cases are classified as essential 
hypertension with the exact cause is unknown. 
It is known that hypertension is associated 
with inflammatory processes. However, until 
then it has not been known for certain whether 
the inflammation is a cause or consequence of 
hypertension.1
The role of inflammation and immunity 
in the pathogenesis of hypertension has been 
widely known. Infiltration of cells in innate 
and adaptive immune system to the kidneys, 
blood vessel wall and area around the blood 
vessels that occurs simultaneously with the 
stages of inflammatory process, such as an 
increase in cytokines release, reactive oxygen 
species (ROS) production and the emergence 
of adhesion molecules, are hallmarks which 
are always found in hypertension.2 The study 
by Yao et al shows an interesting fact about the 
relationship between interleukin-17 (IL-17) and 
hypertension using cross-sectional data adjusted 
for other factors involved in heart disease and 
blood vessels. The data support Harrison and his 
colleagues hypothesis’ stating that Angiotensin 
II stimulation can increase blood pressure 
associated with the activation of the immune 
response and inflammation.3
BASIC CONCEPT OF IMMUNITY
Defense against microbes is mediated by the 
initial reaction of innate immune system followed 
by further response by adaptive immune system. 
Initial mechanism of the immune system to 
fight pathogens are innate immune system.4 
Innate immunity is the front line for the body’s 
defense against microbes. Important components 
of the innate immune system is physical and 
chemical defenses, such as chemical epithel and 
antimicrobials produced in epithelial surface. 
Another component is the phagocytic cells 
(neutrophils and macrophages), dendritic cells, 
Natural Killer cells (NK cells) and lymphocytes. 
Other components are blood proteins, including 
the members of the complement system as well 
as other inflammatory mediators.5
In contrast to innate immunity, there are other 
immune responses that will be stimulated by the 
presence of microorganisms and the exposure 
will increase, both its magnitude and the ability 
to survive, if there is exposure that gives a 
good response to some specific microbes. The 
immune response is called the adaptive immune 
response.6 The innate immune system plays 
an important role in the initiation of adaptive 
immune response. Furthermore, activation of 
adaptive immune response takes 4-7 days, so 
that the innate immune system will be activated 
prior to that time frame.7 Early concepts related 
to adaptive immunity is Antigen Presenting 
Cell (APC) in peripheral tissues that processes 
foreign proteins, such as bacteria and viruses, to 
become a short peptide that is displayed on the 
Major Histocompatibility Complex (MHC).4  The 
characteristics that must be found in adaptive 
immunity is extensive capabilities to identify 
molecules or fragments of molecules with 
different types, either extrinsic or with modified 
structure. In addition, adaptive immune system 
also has the ability to respond aggressively to 
repeated exposure to the same microbe, known 
as memory. Adaptive immune response is 
divided into two: humoral and cellular responses. 
Humoral response will produce antibodies 
reactive with a particular antigen. Antibodies are 
a collection of proteins with similar structures, 
which, if collected collectively, will be the 
immunoglobulin (Ig).7
In addition to cellular components, cytokines 
are important for the development of immune 
responses involving both innate and adaptive 
systems.6 All cells of the immune system may 
produce a minimal number of cytokines and 
express receptors that signal specifically for 
certain types of cytokines. Structured group 
of cytokines that regulate the migration and 
movement of cells are known as chemokines.5 
Cytokines are a large group of proteins that 
dissolve and react in short term, which is 
produced by immune cells and blood vessels, as 
well as serve to activate specific receptors and 
modulate the function of various cells in tissues.8
Both innate and adaptive immune response 
are components of the integrated system derived 
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from the body’s host defenses where a large 
number of cells and molecules work and support 
each other’s function. The working mechanism 
of innate immunity is to provide an effective 
early defense against infection. However, 
unfortunately, many pathogens have the ability 
to resist innate immunity against a variety of 
microbes that elimination of those microbes 
will require stronger immune mechanism, ie 
adaptive immunity. There is some relationships 
between innate and adaptive systems. Innate 
immune response against microbes will stimulate 
adaptive immune response and affect the origin 
of adaptive response. In contrast, the adaptive 
immune response works by enhancing the 
protective mechanisms of innate immunity, thus 
making the innate immune response be effective 
against pathogenic microbes.5 For the immune 
system can be activated, it takes the interaction 
between the phagocytic cells from innate 
immune system and T cells with high specificity 
capabilities from adaptive immune system.
All of these are highly correlated with 
cardiovascular disease since pathogenic microbes 
mentioned above can lead to dramatic changes 
in communication between the cells involved 
to change the function of heart and blood 
vessels. ROS and Reactive Nitrogen Species 
(RNS), which plays an important role in the 
cardiovascular system, are important parts of 
innate immunity.4
BASIC CONCEPT OF INFLAMMATION
Inflammation is a protective response to 
damage or infection of a cell. Inflammation is a 
complex process and involves inflammatory cells 
that will essentially identify the tissues involved, 
then recruit leukocytes to the tissues, eliminating 
the cause of inflammation and repair damaged 
parts of the cell.1
In infection area, macrophages that have 
been dealing with the microbes, will produce 
cytokines (such as tumor necrosis factor (TNF) 
and IL-1) and activate endothelial cells to produce 
selectins, integrins and chemokines.5 To be able 
to enter into the inflamed tissue, the circulating 
leukocytes must stick to endothelial layer of 
the blood vessels walls. This process is called 
extravasation. Leukocyte-specific cell-adhesion 
molecules (CAMs), which is expressed on cell 
surface, serves to regulate the travel path of the 
leukocytes from blood to the tissues around. 
Production of proinflammatory cytokines and 
other inflammatory mediators in inflammatory 
regions will initiate the emergence of CAMs. 
Vascular endothelium, which is known to have 
been inflamed, will experience an extravasation 
process, ie. the displacement of leukocytes to the 
endothelial tissue. In the event of the creation 
of leukocytes interaction with endothelium, 
neutrophils are the first cells that are activated 
by the inflammatory response, which causes the 
neutrophil to stick to the inflamed endothelium. 
Then, they will penetrate the endothelium and 
eventually migrate toward extravascular tissue. 
The process of neutrophil extravasation can be 
divided into four stages, ie. attachment-rolling, 
activation, arrest-adhesion and extravasation.9
In immune system-mediated inflammation, 
the T-helper 1 (Th-1) and T-helper 17 (Th-17) 
cells secrete cytokines that recruit and activate 
leukocytes. IL-17, produced by Th-17 cells, 
activates neutrophils withdrawal. Whereas, 
Interferon-g, produced by Th-1 cells, activates 
macrophages and TNF as well as chemokines, 
which are produced by T-lymphocytes and 
other cells, and is involved in withdrawal 
and activation of various types of leukocytes. 
Although it has been emphasized that the TH-1 
and TH-17 cells are the initial source of these 
cytokines, in cell injury there will be other cells 
that produce similar cytokines. Tissue damage is 
the result of neutrophil and macrophage products 
that have been drawn and activated, such as 
lysosomal enzymes, ROS, nitric oxide (NO) and 
proinflammatory cytokines.5
There is some evidence related to the 
phenotype of proinflammatory cells through a 
vascular  triangle illustrating paralleled vascular 
dysfunction by oxidative stress, both at the 
tissue and at cellular level (Figure 1). The 
vascular dysfunction may occur through several 
mechanisms, including decreased NO level, 
modified LDL, as well as an increase in circulating 
leukocytes adhesion. The inflammatory process 
is an integrated process involving oxidative 
processes and vascular dysfunction, which is 
primarily mediated by transcription factors 
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such as NFkB, with the target of reducing NO 
bioavailability. This cycle occurs naturally, 
in which the stages of vascular dysfunction 
would create an environment that aggravate the 
ongoing inflammation and oxidative stress. In 
2004, Clapp and colleagues conducted a study 
to learn this cycle by inducing an inflammatory 
response in healthy subjects and observed a 
decrease in antioxidant status and endothelial 
function reduction. This study concluded that 
oxidative stress can decrease endothelial function 
by decreasing NO bioavailability.10
It has been recognized that proinflammatory 
cytokines are produced by activated dendritic 
cells, such as IL-1, IL-6 and TNF. These 
proinflammatory cytokines wil l  cause 
vasodilation that increases blood flow to the 
tissues. In addition, inflammatory chemokines 
will also cause some cells to migrate into the 
tissue. IL-1 is used to stimulate lymphocytes 
and macrophage proliferation. Whereas, IL-6 
stimulates the production of acute phase 
proteins derived from liver cells and TNF 
serves to activate neutrophils, endothelial cells, 
lymphocytes and acute phase proteins.7
BASIC CONCEPT OF HYPERTENSION
Activation of the renin-angiotensin-
aldosterone system is one of important 
mechanisms that contribute to the occurrence 
of endothelial dysfunction, vascular remodeling 
and hypertension. Renin, a protease produced by 
the juxtaglomerular cells of the kidney, will break 
angiotensinogen (substrate of renin produced in 
the liver) to angiotensin I, which is converted 
to angiotensin II by the angiotensin converting 
enzyme (ACE). Interactions between angiotensin 
II and receptor G protein-coupled Angiotensin 
1 activates a number of cellular processes that 
contribute to the onset of hypertension and 
accelerate the occurrence of end-organ damage 
associated with hypertension. There is strong 
evidence showing that either aldosterone, 
angiotensin II or even renin, activate several 
signaling pathways that can reduce blood vessels 
function and cause hypertension. Changes of 
structure and function, both from small and 
large arteries, have a major role in hypertensive 
pathogenesis and progress. Endothelial layer in 
the blood vessels is an important component for 
the health of the blood vessels and lead to a solid 
defense to prevent hypertension.11
Figure 1. Vascular Triangle10
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The important role of the kidneys in the long-
term control of blood pressure is through the 
regulation of body fluids and salt homeostasis. 
This is supported by the fact that the ability 
of the kidneys to excrete salt would still be 
decreasing without relying on the causes of 
hypertension, either through the blood, kidneys 
and sympathetic vessels. Relationship between 
the activation of innate and adaptive immune 
system that causes inflammation of the kidneys 
and hypertension have been widely studied. 
Some are by Harrison et al4 and Khodja et 
al2. One characteristic that is frequently found 
is an increase in infiltration of immune cells, 
including macrophages and T lymphocytes, in 
renal interstitial. In addition to the kidney, core 
regulation of blood pressure can be achieved 
through a balance between sympathetic and 
parasympathetic nervous innervation of the 
kidneys and blood vessels, in addition to the 
hypothalamic hormone that regulates thirst, renal 
sodium treatment and the functions of peripheral 
blood vessels and kidneys.12
Over time, endothelial dysfunction, 
neurohormonal activation and an increase in 
blood pressure would lead to remodeling of 
blood vessels. This condition will worsen the 
condition of hypertension. Increasing thickness 
of the medial to lumen part of the blood vessel 
(medial to lumen ratio) is a sign of vascular 
remodeling caused by hypertension, either in 
small arteries or large arteries. Vasoconstriction 
will initiate remodeling of small arteries. 
Normal smooth muscle cells would reconstitute 
themselves around the diameter of the lumen of 
small arteries so that medial portion to the blood 
vessel lumen (medial to lumen ratio) will thicken. 
However, medial cross-sectional area will not 
change. By reducing the diameter of the lumen 
in peripheral circulation, systemic vascular 
resistance will increase so that it will lead to 
the occurrence of hypertension. Instead, lumen 
remodeling of large arteries are characterized by 
the appearance of hypertrophic genes that will 
stimulate an increase in the thickness of medial 
to lumen ratio. The incidence of remodeling 
associated with this hypertrophy will cause an 
increase in the size of vascular smooth muscle 
cells and the accumulation of extracellular matrix 
proteins in smooth muscle, such as collagen, 
due to the activation of the transforming growth 
factor beta (TGF-b).11
Figure 2. Vascular remodelling in hypertension11
IMMUNITY AND INFLAMMATION IN 
HYPERTENSIVE PHYSIOLOGY
Oxidative Stress in Hypertension
Oxidative stress contribution to disrupt renal 
hemodynamic and tubular function has been 
widely studied. Oxidative stress in the kidney is 
commonly found in the study of hypertension. 
These studies affirm that ROS is an important 
media for the occurrence of hypertension caused 
by exposure to angiotensin II.13
There  a re  many  fac to r s  invo lved 
in hypertension, including angiotensin 
II, aldosterone, cytokines and changes in 
mechanical stress in blood vessels, such as 
stretching and tearing, which will stimulate 
the sources of enzymes, such as Nicotinamide 
Adenine Dinucleotide Phosphate (NADPH) 
Oxidase, uncoupled Nitric Oxide Synthase and 
mitochondria, which will produce ROS that 
contribute to hypertension.4 Cells derived from 
innate immune system, such as neutrophils 
and macrophages, will produce ROS such as 
superoxide (O2-) and hydrogen peroxide (H2O2), 
which aims to kill pathogens. NADPH oxidase 
is a major source of ROS production in the 
vasculature.1
Vascular dysfunction is the damage of blood 
vessel function, which is caused by an imbalance 
of different factors in endothelial vasoactive 
substances. One endothelial cell within the blood 
vessels, which is for the protection of outer 
layer, is responsible for the release of several 
vasoactive substances, especially NO. NO is a 
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vasodilator which can cause direct relaxation 
of smooth muscle, blood flow and the delivery 
of the substrate to the tissues. NO also has anti-
atherogenic components that can prevent the 
adhesion of leukocytes and platelets to blood 
vessel walls. The balance between vasodilation 
factors such as NO, with vasoconstriction factors, 
such as endothelin-1 (ET-1), will affect blood 
circulation. The decrease of NO bioavailability 
and/or synthesis of oxide synthase (eNOS) will 
significantly reduces endothelium-dependent 
dilatation (EDD), which will result in varied 
process over time, will reduce the function of 
blood vessels and initiate complications of the 
heart and blood vessels.10
An inflammatory process will continue until 
the inflammation-causing microorganisms can 
be destroyed or tissue repair process has been 
completed. However, chronic inflammatory 
process can trigger excessive ROS produced. 
Oxidative stress is defined as an unbalanced 
condition between ROS production and 
breakdown, which may cause endothelial 
dysfunction.1In normal circumstances, kidneys 
will produce ROS, including anions O2, H2O2, 
peroxynitrite (ONOO¯) and hydroxyl radical 
(OH), which will be efficiently eliminated 
by catalase enzymatic superoxide dismutase 
(SOD), glutathione peroxidase (GPX) and non-
enzymatic systems (glutathione, vitamin C and 
E). ROS Overproduction is related to O2 and will 
culminate in a state of oxidative stress that will 
reduce the biological effects of NO.14
ROS activates transcription factors such 
as Nuclear factor (erythroid-Derived 2)-like 2 
(NFE2L2), Nuclear Factor Kappa-B (NFkB) and 
Activator Protein 1 (AP-I). These transcription 
factors will modulate gene expression, including 
adhesion molecules and chemokines, which 
causes the accumulation of inflammatory 
cells. In the event of an oxidative damage, the 
permeability of the endothelium will increase. 
This will cause an increase in the influx into 
subendothelial space, which will cause oxidation 
and inflammation. Oxidized lipoproteins can 
interact with Toll Like Receptors (TLR), in 
particular the TLR4, which can cause impaired 
blood vessel function. ROS can affect the 
polarization of T cells and cytokine secretion. 
Inflammatory cells such as macrophages and 
granulocytes may release ROS that can aggravate 
oxidative ongoing.4
T-lymphocytes in Hypertension
As described previously, the interaction 
between vascular and inflammatory cells play 
an important role at the beginning and the 
development of hypertension. T cells effector that 
are part of the adaptive immune system, have a 
role in constricting blood vessels in hypertension. 
Signals from central nervous system and APC 
activate T lymphocytes effector and accelerate the 
differentiation through proinflammatory T-helper 
(Th-1) and Th-17 phenotype. Effector cells 
Th-1 and Th-17, produced by proinflammatory 
mediators, participate in inflammation that will 
lead to increased blood pressure and target 
organ damage. Meanwhile, the regulatory T 
lymphocytes act otherwise in hypertension by 
holding innate and adaptive immune responses 
(Figure 3).2
In addition, other than Th-17 cells, another 
division of CD4 +, irrespective of Th-1 and 
Th-2, is the regulatory T cells (Tregs). There 
is recent evidence related to the role of Tregs 
in suppressing the activation of the immune 
response. It is known that natural Tregs produce 
immunosuppressive cytokines like TGF-b and 
IL-10.7 Several recent studies indicate that 
Tregs have a protective effect on hypertension. 
It has been recognized that these Tregs can 
reduce oxidative stress in blood vessels, 
endothelial dysfunction, infiltration of aortic 
macrophages and T cells as well as the levels of 
proinflammatory cytokines circulating in plasma 
circulation. Additionally, adoptive transfer of the 
T-regs may also decrease the incidence of cardiac 
hypertrophy and fibrosis, infiltration of immune 
cells and remodeling effects. Therefore, it can be 
inferred that Tregs have a high antihypertensive 
effect, with regard to its ability to produce anti-
inflammatory cytokines such as IL-10.2
Slight increase in blood pressure in response 
to hypertensive stimulus of such as angiotensin 
II, aldosterone, ET-1, salt diet and genetic 
influences, arising from signal increase in the 
central nervous system. This is likely to cause 
minor damage of the tissue and the formation 
of DAMPs (Damage Associated Molecular 
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Patterns) and neoantigen. This condition may 
trigger APC activation and gradually also 
activate and polarize naïve CD4, effector 
T-lymphocytes via proinflammatory T-helper 
(Th-1) or Th-17 phenotype that contribute to 
damage to blood vessels and kidneys through 
the production of ROS, interferon-g and IL-
17, and may trigger hypertension stability and 
progression of target organ damage. Whereas, 
regulatory T-lymphocytes provide a resistance to 
hypertension and related damage by producing 
IL-10 and suppresses innate and adaptive 
immune responses.1
Proinflammatory Cyokines Release in 
Hypertension
In local inflammatory process, immune 
cells may enter into inflammation area through 
varied chemokines, including Monocyte 
Chemotactic Protein-1 (MCP-1).12 Once it is 
localized in the kidney, immune cells will release 
proinflammatory cytokines such as TNF-a, IL-6, 
IL-1b, IL-17 and interferon-g, where the number 
of proinflammatory cytokines will increase in the 
kidneys and contribute to local tissue damage. 
The role of proinflammatory cytokines in the 
pathogenesis of hypertension is supported by 
studies designed to test the inhibitory effect of 
cytokines on blood pressure. For example, when 
etanercept is injected into the body to reduce 
biological activity of TNF-a in mice, it reduces 
the development of hypertension. It is associated 
with decreased expression of MCP-1 in renal 
cortex. The same event happens in the inhibition 
of IL-6. The occurrence of hypertension can 
be prevented and associated with decreased 
expression of IL-6, macrophage and T cell 
infiltration.15
APCs, like dendritic cells and monocytes or 
macrophages, will carry antigens that present 
in MHC-II towards naïve T cells (Th0) in the 
secondary lymphoid tissues, which will result 
in a differentiation in the form of T effector 
cells such as Th-1, Th-2, Th-17 and regulatory 
T cells that depend on the combined stimulation 
originating from different cytokines. Effector 
T cells lymphocytes and Tregs then migrate to 
vasculature tissues, the tunica adventitia and 
perivascular fat. Effector T lymphocyte cells 
(Th1 and Th17) will activate other immune cells 
and contribute to the onset of inflammation by 
producing proinflammatory cytokines such as 
interferon-g, IL-6 and IL-17. Whereas, regulatory 
T cells will suppress innate and adaptive 
immune response through the production of 
anti-inflammatory cytokines such as IL-10 and 
TGF-b.2
Figure 3. Role of T lymphocytes in Hypertension2
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Several studies have found that IL-6, IL-1 
and TNF-a levels in hypertensive patients will 
be higher than those in patients with normal 
blood pressure.1 In addition, in their study in 
2015, Yao et al.3 have concluded that cytokines 
play an important role in the pathogenesis of 
hypertension.
CONCLUSION
Immunity, inflammation and hypertension 
have proven to be related to each other. 
The activation of those 3 factors triggers an 
inflammatory process, that will and increase 
the blood pressure and leads to organ damage. 
The innate immunity cells, such as neutrophil 
and macrophage, will produce ROS such as 
anion superoxide (O2¯) and hydrogen peroxide 
(H2O2) that leads to reduced bioavailability 
of NO resulting in increase blood pressure. In 
addition to this, T Cell effector and regulatory 
lymphocyte will increase the differentiation 
throughout pro-inflammatory T Helper (Th-1) 
and Th-17 and produce the pro-inflammatory 
cytokines while in the contrary, the Tregs cells 
will suppress the activation of immune system 
and give protective effect against hypertension. 
A numerous research and study should be held 
to discover the relation between immunity, 
inflammation and hypertension in depth. So that 
the new methods in managing hypertension such 
as immunotherapy or even further might reduce 
the prevalence and incidence of hypertension.
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